Content Purpose

All articles must support the mission of Interim Visits by contributing thoughtful, relevant insight to the clinical research community.

Submissions should:

• Address real-world challenges in clinical research or public health
• Provide practical recommendations or operational insight
• Reflect current regulatory and industry standards
• Deliver measurable or strategic value to research professionals

Minimum Structural Requirements

Each article must:

• Contain a clear and relevant title
• Include a defined introduction
• Include at least three clearly labeled sections
• Conclude with a concise summary of key takeaways
• Contain a minimum of 700 words

Paragraphs should be structured clearly and consistently, with logical progression between sections.

Search Visibility & Quality Standards

To ensure strong search performance and professional credibility, each submission must:

• Focus clearly on one primary topic
• Include at least one link to a recognized and authoritative source (such as FDA, ICH, NIH, or peer-reviewed institutions)
• Demonstrate depth, clarity, and subject-matter understanding
• Discuss the primary topic consistently throughout the article
• Introduce the primary topic clearly near the beginning of the content

Content must reflect originality, relevance, and professional integrity. Surface-level commentary or loosely structured content will not meet publication standards.

Submissions that do not meet these requirements will not proceed to publication.

Professional Integrity

All content must be:

• Original
• Accurate and verifiable
• Free from promotional language
• Aligned with current regulatory and ethical standards

The following are not permitted:

• Product marketing
• Sales-oriented messaging
• Unsupported medical claims
• Plagiarized or duplicated material

Editorial Review

All submissions are subject to editorial evaluation to ensure:

• Clarity
• Accuracy
• Relevance
• Structural integrity
• Alignment with the Interim Visits mission

Editorial decisions are final.